Abstract

Preoperative prediction of EGFR mutation status and subtypes is essential to choose appropriate treatment strategies and increase the survival of NSCLC patients. However, existing computer-aided predicting methods mainly focused on the primary tumour and rely on traditional handcrafted-based radiomics features and machine learning classifiers, which have inherent limitations due to huge computation complexity and low accuracy. This study made the first attempt to investigate an end-to-end deep learning technique for detecting EGFR mutations and subtypes based on bone metastasis originated from primary NSCLC. A CM-EfNet was proposed by integrating the convolutional block attention module (CBAM) and multi-resolution feature fusion mechanism (MFM) with EfficientNet v2. For detecting EGFR mutations, the proposed CM-EfNet achieved the highest AUCs of 0.851 and 0.764 in primary and external validation cohorts, respectively. For predicting EGFR mutation sites in exon 19 versus exon 21, the CM-EfNet also generated the highest AUCs of 0.711 and 0.687 in primary and external validation cohorts, respectively. Our research offers a potential non-invasive end-to-end imaging tool for preoperative prediction of EGFR mutations and mutation subtypes for metastatic NSCLCs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.